financetom
Business
financetom
/
Business
/
Nvidia Shares Dip Despite Strong Q4 Earnings Beat, Record Revenue: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia Shares Dip Despite Strong Q4 Earnings Beat, Record Revenue: What's Going On?
Feb 27, 2025 8:30 AM

NVIDIA Corporation ( NVDA ) shares are moving lower Thursday. The stock is reversing amid a possible trader selloff after reporting fourth-quarter financial results.

What To Know: Nvidia ( NVDA ) posted record revenue of $39.3 billion for the fourth quarter, surpassing the consensus estimate of $38.05 billion, according to Benzinga Pro. The company’s top-line results were up 78% year-over-year and 12% sequentially.

Earnings per share came in at 89 cents, versus analyst estimates of 84 cents per share. Nvidia ( NVDA ) reported 82% earnings growth on a year-over-year basis.

Nvidia's ( NVDA ) data center segment led the strong growth, generating $35.6 billion in revenue, up 93% year-over-year. Automotive revenue more than doubled to $570 million, while the gaming and AI PC segment saw a decline, reporting $2.5 billion in revenue, down 11% from the prior year.

The company's full fiscal-year revenue reached $130.5 billion, marking a 114% increase year-over-year and setting a new company record.

“We’ve successfully ramped up the massive-scale production of Blackwell AI supercomputers, achieving billions of dollars in sales in its first quarter. AI is advancing at light speed as agentic AI and physical AI set the stage for the next wave of AI to revolutionize the largest industries,” said Jensen Huang, founder and CEO of Nvidia ( NVDA ).

See Also: Trump’s Plan For Canada, Mexico, China Tariffs To Start March 4 Could Shake Stock Market

Looking ahead, Nvidia ( NVDA ) provided first-quarter revenue guidance of $43 billion, plus or minus 2%, versus estimates of $41.75 billion. The company also expects non-GAAP gross margins to reach 71%.

Following Nvidia's ( NVDA ) quarterly results, several analysts raised price targets.

Truist Securities increased its target from $204 to $205 while maintaining a Buy rating. Morgan Stanley raised its target from $152 to $162 with an Overweight rating. BofA Securities lifted its target from $190 to $200 while maintaining a Buy stance. Needham reiterated its Buy rating with a $160 price target and Rosenblatt maintained a Buy and price target of $220.

NVDA Price Action: Despite the positive financial performance and upward price target revisions, Nvidia ( NVDA ) shares are under pressure on Thursday. Although the stock traded above $135 in early trading, it was down 3.18% at $127.09 at the time of publication, according to Benzinga Pro.

Read Next:

Q4 GDP Holds At 2.3% After Minor Revision In Second Estimate

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kymera Therapeutics Commences $250 Million Public Offering
Kymera Therapeutics Commences $250 Million Public Offering
Jun 25, 2025
04:35 PM EDT, 06/25/2025 (MT Newswires) -- Kymera Therapeutics ( KYMR ) shares fell over 5% during after-hours trading on Wednesday after the company said it commenced a public offering of $250 million of common shares and pre-funded warrants. The company plans to offer underwriters a 30-day overallotment option to buy up to an additional $37.5 million common shares at...
US CDC vaccine panel postpones vote on RSV therapies
US CDC vaccine panel postpones vote on RSV therapies
Jun 25, 2025
June 25 (Reuters) - The U.S. Centers for Disease Control and Prevention's revamped vaccine advisory panel on Wednesday postponed its vote on the use of respiratory syncytial virus therapies to Thursday. The panel, which has convened for a closely watched two-day meeting, was discussing the use of AstraZeneca ( AZN ) and Sanofi's Beyfortus and Merck's ( MRK ) Enflonsia....
Steelcase Posts Higher Fiscal Q1 Results; Sets Q2 Outlook
Steelcase Posts Higher Fiscal Q1 Results; Sets Q2 Outlook
Jun 25, 2025
04:36 PM EDT, 06/25/2025 (MT Newswires) -- Steelcase ( SCS ) reported late Wednesday fiscal Q1 adjusted earnings of $0.20 per diluted share, up from $0.16 a year ago. Analysts polled by FactSet expected $0.14. Revenue for the quarter ended May 30 was $779.0 million, up from $727.3 million a year earlier. Analysts surveyed by FactSet expected $762.4 million. For...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved